CD24 blunts the sensitivity of retinoblastoma to vincristine by modulating autophagy

Retinoblastoma (RB) is the most common childhood malignant intraocular tumor. The clinical efficacy of vincristine (VCR) in the treatment of RB is severely limited by drug resistance. Here, we found that CD24, a GPI‐anchored protein, was overexpressed in human RB tissues and RB cell lines, and was a...

Full description

Bibliographic Details
Main Authors: Jie Sun, Dongju Feng, Huiyu Xi, Jiajing Luo, Zewei Zhou, Qinghuai Liu, Yun Chen, Qing Shao
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Molecular Oncology
Subjects:
Online Access:https://doi.org/10.1002/1878-0261.12708
_version_ 1818879989999730688
author Jie Sun
Dongju Feng
Huiyu Xi
Jiajing Luo
Zewei Zhou
Qinghuai Liu
Yun Chen
Qing Shao
author_facet Jie Sun
Dongju Feng
Huiyu Xi
Jiajing Luo
Zewei Zhou
Qinghuai Liu
Yun Chen
Qing Shao
author_sort Jie Sun
collection DOAJ
description Retinoblastoma (RB) is the most common childhood malignant intraocular tumor. The clinical efficacy of vincristine (VCR) in the treatment of RB is severely limited by drug resistance. Here, we found that CD24, a GPI‐anchored protein, was overexpressed in human RB tissues and RB cell lines, and was associated with the sensitivity of RB cells in response to VCR therapy. We demonstrated that CD24 plays a critical role in impairing RB sensitivity to VCR via regulating autophagy. Mechanistically, CD24 recruits PTEN to the lipid raft domain and regulates the PTEN/AKT/mTORC1 pathway to activate autophagy. Lipid raft localization was essential for CD24 recruitment function. Collectively, our findings revealed a novel role of CD24 in regulating RB sensitivity to VCR and showed that CD24 is a potential target for improving chemotherapeutic sensitivity and RB patient outcomes.
first_indexed 2024-12-19T14:38:51Z
format Article
id doaj.art-497c27d8a7bb4de38d6135cfa69d3396
institution Directory Open Access Journal
issn 1574-7891
1878-0261
language English
last_indexed 2024-12-19T14:38:51Z
publishDate 2020-08-01
publisher Wiley
record_format Article
series Molecular Oncology
spelling doaj.art-497c27d8a7bb4de38d6135cfa69d33962022-12-21T20:17:09ZengWileyMolecular Oncology1574-78911878-02612020-08-011481740175910.1002/1878-0261.12708CD24 blunts the sensitivity of retinoblastoma to vincristine by modulating autophagyJie Sun0Dongju Feng1Huiyu Xi2Jiajing Luo3Zewei Zhou4Qinghuai Liu5Yun Chen6Qing Shao7Department of Ophthalmology the First Affiliated Hospital of Nanjing Medical University Nanjing ChinaDepartment of Immunology Key Laboratory of Immune Microenvironment and Disease Nanjing Medical University Nanjing ChinaDepartment of Ophthalmology the First Affiliated Hospital of Nanjing Medical University Nanjing ChinaDepartment of Immunology Key Laboratory of Immune Microenvironment and Disease Nanjing Medical University Nanjing ChinaDepartment of Immunology Key Laboratory of Immune Microenvironment and Disease Nanjing Medical University Nanjing ChinaDepartment of Ophthalmology the First Affiliated Hospital of Nanjing Medical University Nanjing ChinaDepartment of Immunology Key Laboratory of Immune Microenvironment and Disease Nanjing Medical University Nanjing ChinaDepartment of Ophthalmology the First Affiliated Hospital of Nanjing Medical University Nanjing ChinaRetinoblastoma (RB) is the most common childhood malignant intraocular tumor. The clinical efficacy of vincristine (VCR) in the treatment of RB is severely limited by drug resistance. Here, we found that CD24, a GPI‐anchored protein, was overexpressed in human RB tissues and RB cell lines, and was associated with the sensitivity of RB cells in response to VCR therapy. We demonstrated that CD24 plays a critical role in impairing RB sensitivity to VCR via regulating autophagy. Mechanistically, CD24 recruits PTEN to the lipid raft domain and regulates the PTEN/AKT/mTORC1 pathway to activate autophagy. Lipid raft localization was essential for CD24 recruitment function. Collectively, our findings revealed a novel role of CD24 in regulating RB sensitivity to VCR and showed that CD24 is a potential target for improving chemotherapeutic sensitivity and RB patient outcomes.https://doi.org/10.1002/1878-0261.12708autophagyCD24lipid raftretinoblastomavincristine
spellingShingle Jie Sun
Dongju Feng
Huiyu Xi
Jiajing Luo
Zewei Zhou
Qinghuai Liu
Yun Chen
Qing Shao
CD24 blunts the sensitivity of retinoblastoma to vincristine by modulating autophagy
Molecular Oncology
autophagy
CD24
lipid raft
retinoblastoma
vincristine
title CD24 blunts the sensitivity of retinoblastoma to vincristine by modulating autophagy
title_full CD24 blunts the sensitivity of retinoblastoma to vincristine by modulating autophagy
title_fullStr CD24 blunts the sensitivity of retinoblastoma to vincristine by modulating autophagy
title_full_unstemmed CD24 blunts the sensitivity of retinoblastoma to vincristine by modulating autophagy
title_short CD24 blunts the sensitivity of retinoblastoma to vincristine by modulating autophagy
title_sort cd24 blunts the sensitivity of retinoblastoma to vincristine by modulating autophagy
topic autophagy
CD24
lipid raft
retinoblastoma
vincristine
url https://doi.org/10.1002/1878-0261.12708
work_keys_str_mv AT jiesun cd24bluntsthesensitivityofretinoblastomatovincristinebymodulatingautophagy
AT dongjufeng cd24bluntsthesensitivityofretinoblastomatovincristinebymodulatingautophagy
AT huiyuxi cd24bluntsthesensitivityofretinoblastomatovincristinebymodulatingautophagy
AT jiajingluo cd24bluntsthesensitivityofretinoblastomatovincristinebymodulatingautophagy
AT zeweizhou cd24bluntsthesensitivityofretinoblastomatovincristinebymodulatingautophagy
AT qinghuailiu cd24bluntsthesensitivityofretinoblastomatovincristinebymodulatingautophagy
AT yunchen cd24bluntsthesensitivityofretinoblastomatovincristinebymodulatingautophagy
AT qingshao cd24bluntsthesensitivityofretinoblastomatovincristinebymodulatingautophagy